Intrinsic Value of S&P & Nasdaq Contact Us

Agenus Inc. AGEN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.33
+55.3%

Stock Statistics — AGEN

Agenus Inc. (AGEN) has a market capitalization of $181.24M and trades at $4.72. The 52-week range is 1.38-7.34.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1388.2, Earnings Per Share (EPS) of $0.00, annual revenue of $114.2M.

The stock has a beta of 1.61, operates in the Healthcare sector.

Trading Data
Current Price$4.72
52-Week Range1.38-7.34
Volume2.63M
Avg Volume (30D)672.36K
Market Cap$181.24M
Beta (1Y)1.61
Company
IPO Date2000-02-08
Employees316
CEOGaro H. Armen
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS00847G8042
CUSIP00847G804
Income (Latest Year)
Revenue$114.2M
Gross Profit$103.18M
EBITDA$-10.56M
Operating Income$-20.56M
Net Income$115K
EPS$0.00
EPS Diluted$0.00
Shares Outstanding$29.73M
Balance Sheet (Latest Year)
Total Assets$226.8M
Current Assets$133.44M
Cash & ST Investments$3M
Total Liabilities$504.66M
Total Debt$334.9M
Net Debt$331.9M
Total Equity$-277.86M
Debt / Equity-1.21
Valuation Ratios
P/E Ratio-1388.2
P/S Ratio1.59
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message